Competitive advantage of PET/MRI.

[1]  Felix Nensa,et al.  Simultaneous 18F Choline Positron Emission Tomography/Magnetic Resonance Imaging of the Prostate: Initial Results , 2013, Investigative radiology.

[2]  W. Kalender,et al.  Integrated Whole-Body PET/MR Hybrid Imaging: Clinical Experience , 2013, Investigative radiology.

[3]  Hilmar Kuehl,et al.  Simultaneous 68Ga-DOTATOC PET/MRI in Patients With Gastroenteropancreatic Neuroendocrine Tumors: Initial Results , 2013, Investigative radiology.

[4]  C. Claussen,et al.  Correlation of Simultaneously Acquired Diffusion-Weighted Imaging and 2-Deoxy-[18F] fluoro-2-D-glucose Positron Emission Tomography of Pulmonary Lesions in a Dedicated Whole-Body Magnetic Resonance/Positron Emission Tomography System , 2013, Investigative radiology.

[5]  A. Alavi,et al.  PET/MR imaging: technical aspects and potential clinical applications. , 2013, Radiology.

[6]  K. Akashi,et al.  Standardization of image quality across multiple centers by optimization of acquisition and reconstruction parameters with interim FDG-PET/CT for evaluating diffuse large B cell lymphoma , 2013, Annals of Nuclear Medicine.

[7]  S. Nekolla,et al.  Hybrid PET/MR Imaging of the Heart: Potential, Initial Experiences, and Future Prospects , 2013, The Journal of Nuclear Medicine.

[8]  S. Fürst,et al.  PET/MR: a paradigm shift , 2013, Cancer imaging : the official publication of the International Cancer Imaging Society.

[9]  Evelyn Wenkel,et al.  Toward simultaneous PET/MR breast imaging: systematic evaluation and integration of a radiofrequency breast coil. , 2013, Medical physics.

[10]  Ian Law,et al.  PET/MRI in cancer patients: first experiences and vision from Copenhagen , 2013, Magnetic Resonance Materials in Physics, Biology and Medicine.

[11]  Sune H. Keller,et al.  Image artifacts from MR-based attenuation correction in clinical, whole-body PET/MRI , 2013, Magnetic Resonance Materials in Physics, Biology and Medicine.

[12]  Steve Halligan,et al.  Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI? , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  Sang Yoon Lee,et al.  In-vivo human brain molecular imaging with a brain-dedicated PET/MRI system , 2013, Magnetic Resonance Materials in Physics, Biology and Medicine.

[14]  Susanne Heinzer,et al.  Sequential whole-body PET/MR scanner: concept, clinical use, and optimisation after two years in the clinic. The manufacturer’s perspective , 2013, Magnetic Resonance Materials in Physics, Biology and Medicine.

[15]  V. Schulz,et al.  Challenges and current methods for attenuation correction in PET/MR , 2013, Magnetic Resonance Materials in Physics, Biology and Medicine.

[16]  G. Delso,et al.  PET–MR imaging using a tri-modality PET/CT–MR system with a dedicated shuttle in clinical routine , 2013, Magnetic Resonance Materials in Physics, Biology and Medicine.

[17]  Osman Ratib,et al.  Approaches for the optimization of MR protocols in clinical hybrid PET/MRI studies , 2013, Magnetic Resonance Materials in Physics, Biology and Medicine.

[18]  Arno Villringer,et al.  Physical and organizational provision for installation, regulatory requirements and implementation of a simultaneous hybrid PET/MR-imaging system in an integrated research and clinical setting , 2013, Magnetic Resonance Materials in Physics, Biology and Medicine.

[19]  Habib Zaidi,et al.  Clinical Applications of Hybrid PET/MRI in Neuroimaging , 2013, Clinical nuclear medicine.

[20]  Ciprian Catana,et al.  PET/MRI for Neurologic Applications , 2012, The Journal of Nuclear Medicine.

[21]  Jae Sung Lee,et al.  Comparison of Segmentation-Based Attenuation Correction Methods for PET/MRI: Evaluation of Bone and Liver Standardized Uptake Value with Oncologic PET/CT Data , 2012, The Journal of Nuclear Medicine.

[22]  Stephan G Nekolla,et al.  Attenuation correction for PET/MR: problems, novel approaches and practical solutions. , 2012, Zeitschrift fur medizinische Physik.

[23]  N. Schwenzer,et al.  MR/PET: a new challenge in hybrid imaging. , 2012, AJR. American journal of roentgenology.

[24]  Jiani Hu,et al.  The clinical value of diffusion-weighted imaging in combination with T2-weighted imaging in diagnosing prostate carcinoma: a systematic review and meta-analysis. , 2012, AJR. American journal of roentgenology.

[25]  H. Jadvar.  Molecular imaging of prostate cancer: PET radiotracers. , 2012, AJR. American journal of roentgenology.

[26]  Ciprian Catana,et al.  Simultaneous PET-MRI in oncology: a solution looking for a problem? , 2012, Magnetic resonance imaging.

[27]  Sotirios Bisdas,et al.  Simultaneous PET/MR imaging in a human brain PET/MR system in 50 patients--current state of image quality. , 2012, European journal of radiology.

[28]  Michael Laniado,et al.  PET/MRI in head and neck cancer: initial experience , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[29]  Markus Schwaiger,et al.  Workflow and Scan Protocol Considerations for Integrated Whole-Body PET/MRI in Oncology , 2012, The Journal of Nuclear Medicine.

[30]  Lucie Yang,et al.  Brain amyloid imaging--FDA approval of florbetapir F18 injection. , 2012, The New England journal of medicine.

[31]  P. Bartenstein,et al.  Diagnostic value of combined 18F-FDG PET/MRI for staging and restaging in paediatric oncology , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[32]  Gerald Antoch,et al.  Oncologic PET/MRI, Part 2: Bone Tumors, Soft-Tissue Tumors, Melanoma, and Lymphoma , 2012, The Journal of Nuclear Medicine.

[33]  Ciprian Catana,et al.  MRI-Based Nonrigid Motion Correction in Simultaneous PET/MRI , 2012, The Journal of Nuclear Medicine.

[34]  H. Jadvar.  Hepatocellular carcinoma and gastroenteropancreatic neuroendocrine tumors: potential role of other positron emission tomography radiotracers. , 2012, Seminars in nuclear medicine.

[35]  Andrea Laghi,et al.  New frontiers of MRI in Crohn’s disease: motility imaging, diffusion-weighted imaging, perfusion MRI, MR spectroscopy, molecular imaging, and hybrid imaging (PET/MRI) , 2012, Abdominal Imaging.

[36]  G. Antoch,et al.  Oncologic PET/MRI, Part 1: Tumors of the Brain, Head and Neck, Chest, Abdomen, and Pelvis , 2012, The Journal of Nuclear Medicine.

[37]  A. Drzezga,et al.  First Clinical Experience with Integrated Whole-Body PET/MR: Comparison to PET/CT in Patients with Oncologic Diagnoses , 2012, The Journal of Nuclear Medicine.

[38]  M. Uder,et al.  Comparison of lesion detection between a simultaneously acquiring whole-body PET-MR hybrid scanner and PET-CT , 2012 .

[39]  R. Shah,et al.  Introducing Parametric Fusion PET/MRI of Primary Prostate Cancer , 2012, The Journal of Nuclear Medicine.

[40]  J. Pruvo,et al.  Brain Regional Glucose Uptake Changes in Isolated Cerebellar Cortical Dysplasia: Qualitative Assessment Using Coregistrated FDG-PET/MRI , 2012, The Cerebellum.

[41]  Seiichi Yamamoto,et al.  Simultaneous PET/MR body imaging in rats: initial experiences with an integrated PET/MRI scanner , 2012, Annals of Nuclear Medicine.

[42]  A. Signore,et al.  PET/MRI in infectious and inflammatory diseases: will it be a useful improvement? , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[43]  N. F. Schwenzer,et al.  Whole-body MR/PET: applications in abdominal imaging , 2012, Abdominal Imaging.

[44]  Ahmed Tawakol,et al.  PET/MRI of inflammation in myocardial infarction. , 2012, Journal of the American College of Cardiology.

[45]  G. Delso,et al.  Performance Measurements of the Siemens mMR Integrated Whole-Body PET/MR Scanner , 2011, The Journal of Nuclear Medicine.

[46]  N. Bargalló,et al.  Validation of FDG‐PET/MRI coregistration in nonlesional refractory childhood epilepsy , 2011, Epilepsia.

[47]  T. Beyer,et al.  Effect of MR contrast agents on quantitative accuracy of PET in combined whole-body PET/MR imaging , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[48]  H. Zaidi,et al.  An outlook on future design of hybrid PET/MRI systems. , 2011, Medical physics.

[49]  F. Calabria,et al.  MR-PET fusion imaging in evaluating adnexal lesions: a preliminary study , 2011, La radiologia medica.

[50]  T. Beyer,et al.  Simultaneous 68Ga-DOTATOC-PET/MRI for IMRT treatment planning for meningioma: first experience. , 2011, International journal of radiation oncology, biology, physics.

[51]  Zhang Lin,et al.  Sensitivity of PET/MR images in liver metastases from colorectal carcinoma. , 2011, Hellenic journal of nuclear medicine.

[52]  H. Eskola,et al.  No correlation between glucose metabolism and apparent diffusion coefficient in diffuse large B-cell lymphoma: a PET/CT and DW-MRI study. , 2011, European journal of radiology.

[53]  F. Yin,et al.  SU‐E‐T‐860: Developing a Fast‐Monotonic Descent (FMD) Algorithm for RapidArc Radiotherapy , 2011 .

[54]  H. Zaidi,et al.  Design and performance evaluation of a whole-body Ingenuity TF PET–MRI system , 2011, Physics in medicine and biology.

[55]  N. Shah,et al.  Hybrid 18F-FDG PET–MRI of the hand in rheumatoid arthritis: initial results , 2011, Clinical Rheumatology.

[56]  Zang-Hee Cho,et al.  Observation of Glucose Metabolism in the Thalamic Nuclei by Fusion PET/MRI , 2011, The Journal of Nuclear Medicine.

[57]  Bernd J. Pichler,et al.  Feasibility of simultaneous PET/MR imaging in the head and upper neck area , 2011, European Radiology.

[58]  C. Schiepers,et al.  Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging , 2010, European Radiology.

[59]  Bernd J Pichler,et al.  Combined PET/MRI: one step further in multimodality imaging. , 2010, Trends in molecular medicine.

[60]  Zang-Hee Cho,et al.  Substructural Hippocampal Glucose Metabolism Observed on PET/MRI , 2010, The Journal of Nuclear Medicine.

[61]  J. Felblinger,et al.  omparative study of two whole-body imaging techniques in the case of elanoma metastases : Advantages of multi-contrast MRI examination ncluding a diffusion-weighted sequence in comparison with PET-CT , 2010 .

[62]  C. Catalano,et al.  Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis. , 2010, Radiology.

[63]  Matthias Hofmann,et al.  Hybrid PET/MRI of Intracranial Masses: Initial Experiences and Comparison to PET/CT , 2010, The Journal of Nuclear Medicine.

[64]  A. Alavi,et al.  Diagnostic Performance of FDG-PET, MRI, and Plain Film Radiography (PFR) for the Diagnosis of Osteomyelitis in the Diabetic Foot , 2010, Molecular Imaging and Biology.

[65]  Matthias Hofmann,et al.  Diffusion Tensor Imaging in a Human PET/MR Hybrid System , 2010, Investigative radiology.

[66]  Michael J. Welch,et al.  In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent. , 2010, Bioconjugate chemistry.

[67]  Heinz-Peter Schlemmer,et al.  PET/MRI: Paving the Way for the Next Generation of Clinical Multimodality Imaging Applications , 2010, Journal of Nuclear Medicine.

[68]  Hiroki Kato,et al.  Diagnostic performance of fluorodeoxyglucose positron emission tomography/magnetic resonance imaging fusion images of gynecological malignant tumors: comparison with positron emission tomography/computed tomography , 2010, Japanese Journal of Radiology.

[69]  Cyrill Burger,et al.  Integrating imaging modalities: what makes sense from a workflow perspective? , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[70]  Dae Chul Jung,et al.  Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients. , 2009, European journal of cancer.

[71]  Nassir Navab,et al.  Tissue Classification as a Potential Approach for Attenuation Correction in Whole-Body PET/MRI: Evaluation with PET/CT Data , 2009, Journal of Nuclear Medicine.

[72]  B. Schölkopf,et al.  Towards quantitative PET/MRI: a review of MR-based attenuation correction techniques , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[73]  Gerald Antoch,et al.  Combined PET/MRI: a new dimension in whole-body oncology imaging? , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[74]  Gunnar Brix,et al.  Risks and safety aspects related to PET/MR examinations , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[75]  W. Heiss,et al.  The potential of PET/MR for brain imaging , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[76]  H. Schlemmer,et al.  A look ahead: PET/MR versus PET/CT , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[77]  B. Pichler,et al.  Pre-clinical PET/MR: technological advances and new perspectives in biomedical research , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[78]  R Sankar,et al.  FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsy , 2008, Neurology.

[79]  A. Alavi,et al.  Unparalleled contribution of 18F-FDG PET to medicine over 3 decades. , 2008, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[80]  W. Heiss,et al.  An integrated MR/PET system: prospective applications , 2008, Abdominal Imaging.

[81]  C. Claussen,et al.  Simultaneous Mr/pet Imaging of the Human Brain: Feasibility Study 1 , 2022 .

[82]  G. Greene,et al.  Fluorine-18-deoxyglucose-positron emission tomography imaging with magnetic resonance and computed tomographic correlation in the evaluation of bone and soft-tissue sarcomas: a pictorial essay. , 2008, Current problems in diagnostic radiology.

[83]  Abass Alavi,et al.  Evaluation of Musculoskeletal Disorders with PET, PET/CT, and PET/MR Imaging. , 2008, PET clinics.

[84]  Bradford C. Dickerson,et al.  Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: Insights from functional MRI studies , 2008, Neuropsychologia.

[85]  Armin Kolb,et al.  Positron emission tomography/magnetic resonance imaging: the next generation of multimodality imaging? , 2008, Seminars in nuclear medicine.

[86]  Ciprian Catana,et al.  Simultaneous PET-MRI: a new approach for functional and morphological imaging , 2008, Nature Medicine.

[87]  P. Sachdev,et al.  Diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease: a review , 2008, Current opinion in neurology.

[88]  Maximilian F. Reiser,et al.  Whole-Body Magnetic Resonance Imaging and Positron Emission Tomography-Computed Tomography in Oncology , 2007, Topics in magnetic resonance imaging : TMRI.

[89]  A. Alavi,et al.  Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection? , 2007, Nuclear medicine communications.

[90]  A. Luciani,et al.  MRI and PET in monitoring response in lymphoma , 2005, Cancer imaging : the official publication of the International Cancer Imaging Society.

[91]  C. Snyderman,et al.  Combined PET-CT in the head and neck: part 2. Diagnostic uses and pitfalls of oncologic imaging. , 2005, Radiographics : a review publication of the Radiological Society of North America, Inc.

[92]  Barton F Branstetter,et al.  Combined PET-CT in the head and neck: part 1. Physiologic, altered physiologic, and artifactual FDG uptake. , 2005, Radiographics : a review publication of the Radiological Society of North America, Inc.

[93]  M. Greicius,et al.  Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI , 2004, Proc. Natl. Acad. Sci. USA.

[94]  J. Debatin,et al.  Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. , 2003, JAMA.

[95]  Ralph Weissleder,et al.  Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. , 2003, The New England journal of medicine.

[96]  S. Gambhir.  Molecular imaging of cancer with positron emission tomography , 2002, Nature Reviews Cancer.

[97]  S. Cherry,et al.  Simultaneous PET and MR imaging , 1997, Physics in medicine and biology.

[98]  Patrick Veit-Haibach,et al.  Clinical positron emission tomography/magnetic resonance imaging applications. , 2013, Seminars in nuclear medicine.

[99]  K. Lovblad,et al.  Peripheral nerves, tumors, and hybrid PET-MRI. , 2013, Clinical nuclear medicine.

[100]  S Ted Treves,et al.  Minimizing and communicating radiation risk in pediatric nuclear medicine. , 2011, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[101]  J Roehrig,et al.  The manufacturer's perspective. , 2005, The British journal of radiology.

[102]  W. McGuire,et al.  Breast Cancer 4 , 1981, Springer US.